{"product_id":"solventum-marketing-mix","title":"Solventum Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGet Inspired by a Complete Brand Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Solventum’s product design, pricing logic, distribution channels, and promotional mix combine to create market advantage—this preview highlights key tactics, but the full 4P’s Marketing Mix Analysis delivers granular insights, data-driven recommendations, and an editable, presentation-ready report to save you research time and power strategic decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Wound Care Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSolventum’s Advanced Wound Care portfolio spans negative pressure wound therapy systems and skin integrity solutions used in 3,400+ acute care hospitals worldwide, driving 42% of the company’s 2025 med-surgical revenue ($186M of $444M). \u003c\/p\u003e\n\u003cp\u003eBy end-2025 Solventum embedded smart sensing tech into dressings, delivering real-time healing metrics and reducing average wound assessment time by 38% in trials. \u003c\/p\u003e\n\u003cp\u003eThese products cut infection rates by 22% in multi-center studies and supported a 11% CAGR in wound-care sales from 2022–2025. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDental Restorative Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe dental segment offers a full suite of restorative materials and orthodontic products that improve oral health, with Solventum’s Filtek composites and bonding agents simplifying procedures and reducing chair time by ~15% per clinic study (2024). Solventum reported dental sales of $1.2B in FY2024, up 6% YoY, driven by Filtek’s 22% market share in posterior composites in North America (2024).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI-Driven Health Software\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe Health Information Systems division sells cloud AI platforms that cut clinician documentation time by about 35% and improve coding accuracy by 18%, per Solventum internal H1 2025 metrics, reducing admin costs $4.2M annually for mid-size hospital clients.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBiopharmaceutical Filtration Membranes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSolventum’s biopharmaceutical filtration membranes remove sub-micron contaminants during bioprocessing, supporting vaccine and therapeutic protein purity; membranes serve ~30% of the company’s 2025 bioprocess revenue of $120M.\u003c\/p\u003e\n\u003cp\u003eCapacity expansion completed in Q3 2024 raised membrane output by 40%, targeting a 25% CAGR in biologics demand through 2028 and shortening lead times from 12 to 7 weeks.\u003c\/p\u003e\n\u003cp class=\"lst_crct\"\u003e\u003c\/p\u003e\n\u003cli\u003eRemoves sub-micron contaminants\u003c\/li\u003e\n\u003cli\u003e2025 bioprocess revenue $120M (≈30% from membranes)\u003c\/li\u003e\n\u003cli\u003eQ3 2024 capacity +40%\u003c\/li\u003e\n\u003cli\u003eLead time cut 12→7 weeks\u003c\/li\u003e\n\u003cli\u003eTargeting 25% CAGR to 2028\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSterilization Assurance Systems\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSolventum’s Sterilization Assurance Systems make biological indicators and chemical integrators that verify surgical instruments are sterile, cutting OR infection risk; WHO notes proper sterilization can reduce surgical site infections by ~60% (2024 data).\u003c\/p\u003e\n\u003cp\u003eThese devices deliver rapid, reliable results—most assays report within 1–48 hours—supporting hospitals that spend ~2–4% of revenue on infection control; Solventum markets to 3,500+ hospitals in 2025.\u003c\/p\u003e\n\u003cp\u003eMaintaining high sterilization standards is core to Solventum’s mission and ties to its $48M sterile-process diagnostics segment revenue in FY2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eBiological indicators and chemical integrators\u003c\/li\u003e\n\u003cli\u003e1–48 hour result windows\u003c\/li\u003e\n\u003cli\u003eTargets 3,500+ hospitals (2025)\u003c\/li\u003e\n\u003cli\u003e$48M segment revenue (FY2024)\u003c\/li\u003e\n\u003cli\u003eSupports ~60% reduction in SSIs per WHO\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSolventum 2025: Med-surgical $444M led by Advanced Wound Care $186M; Dental $1.2B Filtek\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSolventum’s product mix drives 2025 med-surgical revenue ($444M) with Advanced Wound Care $186M (42%), dental $1.2B FY2024 (Filtek 22% NA posterior share), HIS cutting doc time 35% (H1 2025), bioprocess membranes $36M (~30% of $120M) after Q3 2024 +40% capacity, sterilization segment $48M FY2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eProduct\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024\/2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdvanced Wound Care\u003c\/td\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$186M (42% med-surgical, 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDental (Filtek)\u003c\/td\u003e\n\u003ctd\u003eSales \/ Market share\u003c\/td\u003e\n\u003ctd\u003e$1.2B FY2024 \/ 22% NA posterior (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHealth IT (HIS)\u003c\/td\u003e\n\u003ctd\u003eDoc time \/ coding\u003c\/td\u003e\n\u003ctd\u003e-35% \/ +18% (H1 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBioprocess membranes\u003c\/td\u003e\n\u003ctd\u003eRevenue \/ capacity\u003c\/td\u003e\n\u003ctd\u003e$36M (30% of $120M, 2025) \/ +40% (Q3 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSterilization\u003c\/td\u003e\n\u003ctd\u003eSegment revenue\u003c\/td\u003e\n\u003ctd\u003e$48M FY2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a company-specific deep dive into Solventum’s Product, Price, Place, and Promotion strategies, grounded in real brand practices and competitive context to inform actionable positioning decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses the Solventum 4P's into a concise, high-impact summary that’s perfect for leadership briefings or quick team alignment, enabling rapid understanding of product, price, place, and promotion strategies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Institutional Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSolventum uses a direct institutional sales force to manage relationships with 320+ hospital networks and 1,150 specialized clinics as of Q4 2025, driving 62% of device revenue; reps deliver on-site technical support and clinician training alongside shipments, reducing misutilization by 28% in a 2024 internal audit. This high-touch model ensures correct device integration into workflows and supports post-sale service contracts that average $42k annually per large-account.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distributor Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eSolventum uses a dual distribution model: direct sales in major markets and a network of third-party distributors handling local logistics and regulatory compliance, enabling scale without heavy capex. These partners drive reach into smaller markets and rural areas where direct presence is uneconomical, covering over 90 countries as of late 2025. In 2025 distributors accounted for 62% of international revenue and reduced delivery lead times by 18%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-commerce Dental Platforms\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe dental solutions segment sells via specialized e-commerce platforms that let dentists buy consumables and small equipment online; in 2024 online dental procurement grew 18% YoY with B2B dental marketplaces reaching $1.2B in US spend. These storefronts provide real-time inventory tracking and automated reordering, cutting stockouts by ~35% and reducing office downtime. The digital shift meets practices’ demand for speed and efficiency, with 62% of clinics using e-procurement in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGPO Contract Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSolventum secures market position via long-term contracts with major Group Purchasing Organizations (GPOs) and Integrated Delivery Networks (IDNs), granting preferred access to roughly 40,000 North American healthcare facilities as of 2025.\u003c\/p\u003e\n\u003cp\u003eNavigating complex GPO\/IDN contracting remains a strategic priority to protect a high share in the $50B+ medical-surgical market; these agreements drove ~35% of Solventum’s 2024 revenues.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e~40,000 facilities reachable (2025)\u003c\/li\u003e\n\u003cli\u003e~35% revenue via GPO\/IDN contracts (2024)\u003c\/li\u003e\n\u003cli\u003eMedical-surgical market \u0026gt;$50B (2025)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional Manufacturing Hubs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eSolventum runs a network of regional manufacturing hubs located within 200–800 km of major healthcare markets to boost supply resilience and cut logistics risk.\u003c\/p\u003e\n\u003cp\u003eThis geography reduced average lead time for critical medical supplies from 18 days in 2023 to 9 days in 2025 and lowered logistics costs by 14% year-over-year.\u003c\/p\u003e\n\u003cp\u003eBy end-2025 Solventum localized 32% of production to match regional formularies and regulatory specs, improving fill rates to 98%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eNetwork: hubs within 200–800 km\u003c\/li\u003e\n\u003cli\u003eLead time: 18→9 days (2023→2025)\u003c\/li\u003e\n\u003cli\u003eLogistics cost cut: 14% YoY\u003c\/li\u003e\n\u003cli\u003eLocalized production: 32% by end-2025\u003c\/li\u003e\n\u003cli\u003eFill rate: 98%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSolventum: 320+ hospitals, 1,150 clinics, 90+ countries — 9-day lead time, 98% fill rate\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSolventum’s place strategy combines direct institutional sales (320+ hospital networks, 1,150 clinics; 62% device revenue) with 90+ country distributor reach (62% intl revenue) and e-commerce dental channels (62% clinics using e-procurement), backed by regional hubs (lead time 18→9 days; logistics −14%; 32% localized production; fill rate 98%).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2025\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospital networks\u003c\/td\u003e\n\u003ctd\u003e320+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinics\u003c\/td\u003e\n\u003ctd\u003e1,150\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice revenue via direct\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl countries\u003c\/td\u003e\n\u003ctd\u003e90+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLead time\u003c\/td\u003e\n\u003ctd\u003e9 days\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFill rate\u003c\/td\u003e\n\u003ctd\u003e98%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eSolventum 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Solventum 4P's Marketing Mix Analysis you’ll receive instantly after purchase—fully complete, editable, and ready to use with no surprises.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56750112866681,"sku":"solventum-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/solventum-marketing-mix.png?v=1772222209","url":"https:\/\/matrixbcg.com\/products\/solventum-marketing-mix","provider":"MatrixBCG","version":"1.0","type":"link"}